Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U01DE016750 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Washington | OTHER |
| National Institute of Dental and Craniofacial Research (NIDCR) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents
The purpose of this study was to test two dental products used as direct pulp capping agent for the permanent teeth. The two products were mineral trioxide aggregate and calcium hydroxide.
A direct pulp capping consists of covering an exposed tooth pulp (the inside portion of the tooth where the blood vessels and nerve supply the tooth) with a medication to maintain tooth vitality. Different events can cause the pulp to be exposed, for example a deep cavity, or an accident where the outer portion of the tooth fractures. When this occurs, it is sometimes possible to place a medicine over the top of the exposure (a "cap") in an effort to allow the pulp to heal on its own. Our study intended to compare two of those medicines, calcium hydroxide and mineral trioxide aggregate, both Federal Drug Administration (FDA) approved products, to determine if one performed better than the other.
The study was conducted with patients recruited by Northwest PRECEDENT practitioners. The practitioners interested in participating in the study were randomized (assigned by chance) to one of the two intervention groups: a treatment group (mineral trioxide aggregate) and a control group (calcium hydroxide).
Direct pulp capping was completed on permanent (adult) teeth with pulps exposed due to decay, trauma (injury) or mechanical exposure. Treated teeth were followed over two years to determine how well they responded to the treatment.
All patients who had a pulp exposure of a permanent tooth were eligible for the study. These patients were further asked to participate in the study if they satisfied the inclusion criteria for the study and did not present any of the exclusion criteria stated in the study protocol.
A tooth that received a pulp cap was treated in the following manner: After a tooth pulp had been exposed and the tooth was found to be suitable for a pulp cap, the exposure and surrounding area was cleaned by gentle rinsing with water. A cotton pellet moistened with 5.25% sodium hypochlorite was placed over the exposure and allowed to sit for 1-2 minutes. This procedure was used to control pulp bleeding and remove the germs from that area. After the initial period, the cotton pellet was removed and the area inspected. If bleeding continued, a new cotton pellet moistened in the sodium hypochlorite solution was reapplied to the area for an additional several minutes. This was repeated until bleeding was controlled or the practitioner decided that pulp capping was not appropriate for the situation. Once the bleeding was controlled from the exposure, one of the two pulp capping agents was applied to the pulp exposure site.
Practices were assigned by chance into one of two treatment groups, those that completed direct pulp capping with mineral trioxide aggregate and those that completed direct pulp capping with calcium hydroxide, both FDA approved agents for this purpose. The handling characteristics of the two materials were so different, that it was not practical to blind the practitioners as to which material they were using. Likewise, training in the use of each material was required. It was believed that it was more important that the practitioner become familiar and competent in the use of one of the materials to ensure it was used appropriately, than it was to have practitioners use both materials and confuse procedures between them. Since time was a critical element in the success or failure of direct pulp capping, the patients were consented to participate in the study after the procedure was done. A resin-modified glass ionomer liner (e.g. Vitrebond, Fuji Lining Cement, Fuji II LC, Vitremer) was placed over the pulp capping agent. This liner sealed the pulp capping agent and protected the pulp from being infiltrated with bacteria. After the resin-modified glass ionomer lining material was set, the final filling was placed.
Two types of instruments were used in this study:
Study participant data collection form This form collected two types of data: demographic and clinical data. The demographic part gathered information regarding patient age, gender, and race. The clinical form collected data regarding the clinical and x-ray evaluation of the tooth treated with a direct pulp cap: condition of the tooth, the type of pulp exposure (by decay, by injury or during tooth preparation), patients' complaints regarding the tooth, and results of diagnostic tests (x-ray, pain to biting or temperature, etc) were recorded.
Practitioner feedback survey A survey was administered to all practitioners who participated in the study. This survey included a series of questions designed to evaluate the communication between the member practitioners and the network, practitioner/staff training, patient recruitment, obtaining informed consent, data collection and data transmission, including the electronic data capture system. The survey also tried to determine how well the offices were able to combine the research in a regular daily office schedule in order to determine if a research project would affect the normal day-to-day routine.
The intent of this study was to find out which of the two products yielded better results as a pulp capping agent. In order to detect this, the failure rates in the two treatment groups were compared using statistical tests. Distributions of covariates in the two treatment groups were compared and clinical judgment was used to identify covariates with serious group imbalances that would cause an unusual result for the primary analysis. Logistic regression was used to compare failure rates while adjusting for any covariates that were imbalanced between groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mineral Trioxide Aggregate | Active Comparator | Pulp capping agent, Mineral Trioxide Aggregate used as a direct pulp cap |
|
| Calcium Hydroxide | Active Comparator | Pulp capping agent, Calcium Hydroxide used as a direct pulp cap |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mineral Trioxide Aggregate | Drug | Pulp capping agent, Mineral TrioxideAggregate |
|
| Measure | Description | Time Frame |
|---|---|---|
| Tooth Survival | No recommendation for tooth extraction or root canal therapy. Only one tooth was enrolled/assessed per participant. | Up to two years |
| Measure | Description | Time Frame |
|---|---|---|
| Pulp Vitality | No evidence of pulpal resorption or calcification or periradicular radiolucency | Up to two years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Hilton, DMD, MS | NW PRECEDENT | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Oregon Health & Science University | Portland | Oregon | 97239 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 19830978 | Background | Hilton TJ. Keys to clinical success with pulp capping: a review of the literature. Oper Dent. 2009 Sep-Oct;34(5):615-25. doi: 10.2341/09-132-0. No abstract available. | |
| 23690353 | Result | Hilton TJ, Ferracane JL, Mancl L; Northwest Practice-based Research Collaborative in Evidence-based Dentistry (NWP). Comparison of CaOH with MTA for direct pulp capping: a PBRN randomized clinical trial. J Dent Res. 2013 Jul;92(7 Suppl):16S-22S. doi: 10.1177/0022034513484336. Epub 2013 May 20. |
Not provided
Not provided
Randomization was done on a practice level rather than a patient level. The handling characteristics of the two materials were so dissimilar that it was not feasible to blind the practitioners as to which material they were using.
Thirty-five dental practices recruited and enrolled subjects between May 2009 and March 2011.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Mineral Trioxide Aggregate | Pulp capping agent, Mineral Trioxide Aggregate used as a direct pulp cap |
| FG001 | Calcium Hydroxide | Pulp capping agent, Calcium Hydroxide used as a direct pulp cap |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Mineral Trioxide Aggregate | Pulp capping agent, Mineral Trioxide Aggregate used as a direct pulp cap |
| BG001 | Calcium Hydroxide | Pulp capping agent, Calcium Hydroxide used as a direct pulp cap |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Tooth Survival | No recommendation for tooth extraction or root canal therapy. Only one tooth was enrolled/assessed per participant. | 12 subjects were excluded in the Mineral Trioxide Aggregate group due to lack of follow-up (4 subjects were non-responsive; unable to contact 6 subjects; 2 subjects changed dentists) and 6 subjects were in the Calcium Hydroxide group (2 subjects were non-responsive; unable to contact 3 subjects; 1 subject was incarcerated). | Posted | Number | participants | Up to two years |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Mineral Trioxide Aggregate | Pulp capping agent, Mineral Trioxide Aggregate used as a direct pulp cap |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Death of patient | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment | Ovarian cancer |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Not feeling well | General disorders | Non-systematic Assessment | Possibly nausea due to pain medication. |
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Thomas J. Hilton | Oregon Health & Science University | 503.494.8672 | hiltont@ohsu.edu |
Not provided
| ID | Term |
|---|---|
| D003789 | Dental Pulp Exposure |
| ID | Term |
|---|---|
| D003788 | Dental Pulp Diseases |
| D014076 | Tooth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C086631 | mineral trioxide aggregate |
| D000068437 | Pemetrexed |
| D002126 | Calcium Hydroxide |
| ID | Term |
|---|---|
| D006147 | Guanine |
| D007042 | Hypoxanthines |
| D011688 | Purinones |
| D011687 | Purines |
| D006574 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Calcium Hydroxide | Drug | Pulp capping agent, Calcium Hydroxide |
|
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
Pulp capping agent, Calcium Hydroxide used as a direct pulp cap
|
|
|
| Secondary | Pulp Vitality | No evidence of pulpal resorption or calcification or periradicular radiolucency | Posted | Number | participants | Up to two years |
|
|
|
| 2 |
| 195 |
| 5 |
| 195 |
| EG001 | Calcium Hydroxide | Pulp capping agent, Calcium Hydroxide used as a direct pulp cap | 1 | 181 | 2 | 181 |
|
| Death of Patient | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Systematic Assessment | Lung cancer |
|
| Death of patient | Respiratory, thoracic and mediastinal disorders | Systematic Assessment | Pulmonary embolism |
|
|
| H1N1 flu | Gastrointestinal disorders | Non-systematic Assessment | Cough and fever |
|
| Toothache on non-study tooth | Infections and infestations | Non-systematic Assessment | Carious tooth |
|
| Temperature sensitivity and dull ache in upper left quadrant | Infections and infestations | Non-systematic Assessment | Probably related to caries in study tooth |
|
| Diabetes | Metabolism and nutrition disorders | Systematic Assessment | Diagnosed while participating in study |
|
Not provided
Not provided
| Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D005971 | Glutamates |
| D024342 | Amino Acids, Acidic |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
| D000600 | Amino Acids, Dicarboxylic |
| D006878 | Hydroxides |
| D000468 | Alkalies |
| D007287 | Inorganic Chemicals |
| D017610 | Calcium Compounds |
| D000838 | Anions |
| D007477 | Ions |
| D004573 | Electrolytes |